Zydus receives final approval from US FDA for Vigabatrin tablets
Vigabatrin is used to treat babies, one month to two years old with infantile spasms
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus
EMA grants Orphan Drug Designation to Saroglitazar Mg for treating patients with PBC
The Orphan drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare,…
Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at AASLD event
The Liver Meeting Digital Experience 2020 is taking place virtually from November 13-16, 2020
Zydus and CMS partnership provides boost to commercialsation strategy for desidustat in China, says…
CMS will be responsible for the development, registration and commercialisation of desidustat in China, while Zydus will receive…
Zydus and CMS enter pact for Desidustat in Greater China
The agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease…
Zydus settles patent case over Aptalis’ drug Canasa
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Zydus to tie up with US-based research centre
To develop a vaccine against visceral leishmaniasis
Zydus to tie up with US-based research centre to develop vaccine
Etna Biotech will also donate $2,40,000 for advancing research under the NIH leishmaniasis programme